The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults

25Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine and which DMARD they are receiving.

References Powered by Scopus

This article is free to access.

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Day, A. L., Winthrop, K. L., & Curtis, J. R. (2020). The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults. Cleveland Clinic Journal of Medicine, 87(11), 695–703. https://doi.org/10.3949/ccjm.87a.20056

Readers over time

‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

67%

Lecturer / Post doc 2

22%

Researcher 1

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

67%

Biochemistry, Genetics and Molecular Bi... 2

13%

Nursing and Health Professions 2

13%

Social Sciences 1

7%

Article Metrics

Tooltip
Mentions
News Mentions: 2

Save time finding and organizing research with Mendeley

Sign up for free
0